River BioMedics

Private

EnschedeHealthcare & Life Scienceshttps://riverbiomedics.com/

Last Round

Grant

Jul 5, 2023

Total Funding Raised

$5.78M

Company Overview

River BioMedics is a biotechnology company that develops 3D human cardiac models for target validation and drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

3D cardiac modelsheart-on-a-chiphiPSChuman induced pluripotent stem cellspreclinical drug discoverycardiovascular disease modelsorgan-on-a-chipin vitro cardiac tissuedrug efficacy testingpreclinical translationbiotech servicesassay developmentcardiac safety screeningmicrofluidicspredictive toxicology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

River BioMedics Comparables

Compare River BioMedics with similar companies based on industry and business-model similarity.

River BioMedics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
HeartBeat.bio AG	87%
Ncardia	81%
BiomimX	81%

View all Comparables

River BioMedics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Jul 5, 2023
Grant	Jan 24, 2023
Seed	Jan 20, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Nicky Cooper

CEO

Executive Team

River BioMedics Investors

Notable investors and investment history

River BioMedics investors
Investor	Rounds
European Innovation Council Fund	Grant
Libertatis Ergo Holding	Grant
First Fund	Grant, Seed
KIKK Capital	Grant, Seed
BioGeneration Ventures	Grant, Seed
European Innovation Council Fund	Grant
Oost NL	Grant, Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 25, 2025
Presented latest work on 3D cardiac strips at MPS 2025.

View all signals

River BioMedics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

River BioMedics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about River BioMedics's valuation, stock price, and market status.

Firmographic Details

HeadquartersEnschede

Employee Range12

Year Founded2020

Last FundingJul 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.